Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.
D007516:Adenoma, Islet Cell / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000235:genetics* / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism; D005755:Gastrins / Q000378:metabolism; D005934:Glucagon; D005951:Glucose Tolerance Test; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D010375:Pedigree; D014044:Tolbutamide; D015043:Zollinger-Ellison Syndrome / Q000209:etiology / Q000235:genetics
D005755:Gastrins; D007328:Insulin; D005934:Glucagon; D014044:Tolbutamide; D003981:Diazoxide